Amgen Oncology Assistance: 1-800-272-9376
In conjunction with the recent FDA approval of Vectibix (panitumumab), Amgen announced a new program, Amgen Oncology Assistance (AOA), to assist patients who are uninsured, underinsured or unable to afford their insurance copayments. Another way Amgen is improving access to care is the Vectibix Cap that will limit total patient copayments regardless of insurance or income.
Genentech Access to Care Foundation
1 DNA Way, MS #13A
South San Francisco, CA 94080
FAX: (650) 225-1366
Genentech has established the Genentech Access to Care Foundation to ensure patients have access to all Genentech marketed drugs. Since 1990, Genentech has donated $700 million of free product to uninsured patients. In order to qualify for this program, there are certain requirements including income restrictions.
Pfizer offers FirstRESOURCE to assist eligible, low income, uninsured and underinsured patients.
Erbitux Patient Assistance Program: 1-800-736-0003
Bristol-Myers Squibb offers assistance to patients who receive or plan to receive Erbitux. Patients must meet eligibility requirements.
Patient Assistance Program: 1-800-996-6626
Patients who meet eligibility requirements can receive assistance with drugs as well as alternative services to help locate other avenues of help during their treatment.
The Colorectal CareLine Case Management program services are made possible through the generous support of Amgen Oncology, sanofi-aventis and Genentech, A Member of the Roche Group.